The Global Epigenetics Market The increasing cases of cancer is expected to foster healthy growth of the market during the forecast period, states Fortune Business Insights in a report, titled “Epigenetics Market Size, Share & Industry Analysis, By Product Type (Instruments, Consumables), By Technology (DNA Methylation, Histone Methylation, Histone Acetylation, Others), By Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Others), By End User (Academic & Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organisations, Others)Others and Regional Forecast, 2020-2027.” the increasing development of novel treatment and therapies by key players is likely to promote the growth of the market.
Get Sample Report On Global Epigenetics Market :
What does the Report Include?
The market report includes qualitative and quantitative analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers different regions, contributing to the growth of the market. It includes the competitive landscape that involves the leading companies and the adoption of strategies to announce partnerships, introduce new products, and collaborate that will further contribute to the growth of the market between 2020 and 2027. Moreover, the research analyst has adopted several research methodologies such as SWOT and PESTEL analysis to extract information about the current trends and industry developments that will drive the market growth during the forecast period.
The COVID-19 pandemic has triggered unprecedented economic uncertainty in the business world. While some businesses are in a relatively insulated due to low exposure, many others have been unable to escape the effects of the pandemic and are struggling financially. We aim to provide businesses with thoroughly researched market intelligence reports regarding this crisis so that they can formulate well-informed market strategies.
Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Increased Government Funding for Diagnosis to Contribute Growth
The increasing prevalence of cancer around the world is a key factor expected to foster the growth of the market. According to the American Cancer Society, in the U.S., the number of new cancer cases increased to 1,688,780 in 2017 from 1,685,210 in 2016. The increasing research and development activities for the development of innovative therapeutics is predicted to aid the expansion of the market. For instance, in February 2016, the University of Southampton and University Hospitals Southampton NHS Foundation Trust (UK) received USD 1.57 million (GBP 1 million) for genetics and genomics research related to cancer and infectious diseases. The growing cancer patients in developed as well as developing nations is expected to augur well for the market. WHO estimates, people suffering from cancer is expected to increase to 19.3 million by 2025 from 14.1 million in 2012. The increasing partnerships and agreements among major companies is likely to propel healthy growth of the market. For instance, In October 2017, Cambridge Epigenetix,a bioscience company announced the collaboration with NuGEN Technologies for the distribution of TrueMethyl oxidative bisulfite sequencing (oxBS-Seq) kits in the UK. The next-generation sequencing (NGS) kits will be used for epigenetic marker identification and quantification.
Out research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.
Well-established Healthcare Infrastructure to Boost Growth in North America
Geographically, the global market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America followed by Europe is predicted to dominate the market during the forecast period. The growth in the regions is attributed to the strong funding by the government for research activities on epigenetics. The presence of advanced healthcare facilities and enhanced diagnostic procedures is predicted to aid development in North America. The increasing investment in R&D by key players is likely to favor growth in Europe. For instance, in March 2015, Barts Cancer Institute’s Centre for Haemato-Oncology (UK) received funds worth USD 113.9 million (GBP 860,000) from the Medical Research Council to study epigenetic changes in cancer. Asia Pacific is predicted to hold maximum share in the market during the forecast period owing to the rising disposable income and high unmet clinical needs of patients. The increasing awareness about early diagnosis in emerging countries, such as India and China is predicted to bolster the healthy growth of the market.
Key questions answered in the report:
- What will the market growth rate of Epigenetics Market in 2026?
- What are the key factors driving the global Epigenetics Market ?
- Who are the key manufacturers in Epigenetics Market space?
- What are the market opportunities, market risk and market overview of the Epigenetics Global market?
- What are sales, revenue, and price analysis of top manufacturers of Epigenetics Global market?
- What are sales, revenue, and price analysis by types and applications of Epigenetics Market ?
- What are sales, revenue, and price analysis by regions of Epigenetics Market ?
Table Of Content:
1 Market Overview
1.1 Epigenetics Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
220.127.116.11 United States Market States and Outlook (2020-2026)
18.104.22.168 Canada Market States and Outlook (2020-2026)
22.214.171.124 Mexico Market States and Outlook (2020-2026)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
126.96.36.199 Germany Market States and Outlook (2020-2026)
188.8.131.52 France Market States and Outlook (2020-2026)
184.108.40.206 UK Market States and Outlook (2020-2026)
220.127.116.11 Russia Market States and Outlook (2020-2026)
18.104.22.168 Italy Market States and Outlook (2020-2026)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
22.214.171.124 China Market States and Outlook (2020-2026)
126.96.36.199 Japan Market States and Outlook (2020-2026)
188.8.131.52 Korea Market States and Outlook (2020-2026)
184.108.40.206 India Market States and Outlook (2020-2026)
220.127.116.11 Southeast Asia Market States and Outlook (2020-2026)
1.4.4 South America, Middle East and Africa
18.104.22.168 Brazil Market States and Outlook (2020-2026)
22.214.171.124 États et perspectives du marché égyptien (2020-2026)
126.96.36.199 États et perspectives du marché de l’Arabie saoudite (2020-2026)
188.8.131.52 États et perspectives du marché sud-africain (2020-2026)
184.108.40.206 États et perspectives du marché de la Turquie (2020-2026)
1.5 Dynamique du marché
1.5.1 Opportunités de marché
1.5.2 Risque de marché
1.5.3 Force motrice du marché
2 profils de fabricants
3 Ventes mondiales d’épigénétique, revenus, part de marché et concurrence par fabricant (2017-2018)
3.1 Ventes mondiales d’épigénétique et part de marché par fabricant (2017-2018)
3.2 Revenus mondiaux de l’épigénétique et part de marché par fabricant (2017-2018)
3.3 Taux de concentration du marché
3.3.1 Part de marché des 3 principaux fabricants d’épigénétiques en 2018
3.3.2 Part de marché des 6 principaux fabricants d’épigénétiques en 2018
3.4 Tendance de la concurrence sur le marché
4 Analyse globale du marché de l’épigénétique par régions
4.1 Ventes mondiales d’épigénétique, revenus et part de marché par régions
4.1.1 Ventes mondiales d’épigénétique et part de marché par régions (2020-2019)
4.1.2 Chiffre d’affaires mondial de l’épigénétique et part de marché par régions (2020-2019)
4.2 Ventes et taux de croissance de l’épigénétique en Amérique du Nord (2020-2019)
4.3 Ventes et taux de croissance de l’épigénétique en Europe (2020-2019)
4.4 Ventes et taux de croissance de l’épigénétique en Asie-Pacifique (2020-2019)
4.5 Ventes et taux de croissance de l’épigénétique en Amérique du Sud (2020-2019)
4.6 Ventes et taux de croissance de l’épigénétique au Moyen-Orient et en Afrique (2020-2019)
Fortune Business Insights Pvt. Ltd.
308, Quartier général suprême,
Enquête n° 36, Baner,
411045, Maharashtra, Inde.
États-Unis : +1 424 253 0390
Royaume-Uni : +44 2071 939123
APAC : +91 744 740 1245